Liquidia (LQDA) Current Assets (2019 - 2026)
Liquidia's (LQDA) quarterly Current Assets came in at $333.1 million in Q1 2026, up 87.95% year-on-year from $177.2 million in Q1 2025, and up 21.82% quarter-over-quarter from $273.4 million in Q4 2025.
Liquidia (LQDA) Current Assets (2019 - 2026) Analysis & Trends
Liquidia's Current Assets history runs 8 years deep, the most recent figure standing at $333.1 million for Q1 2026.
- On a quarterly basis, Current Assets rose 87.95% year-over-year to $333.1 million in Q1 2026; TTM through Mar 2026 was $333.1 million, a 87.95% increase from a year earlier, with the FY2025 full-year figure at $273.4 million, up 47.7% from the prior year.
- Current Assets grew to $333.1 million in Q1 2026 per LQDA's latest filing, from $273.4 million in the prior quarter.
- Across five years, Current Assets topped out at $333.1 million in Q1 2026 and bottomed at $62.0 million in Q1 2022.
- The 5-year median for Current Assets is $147.3 million (2024), against an average of $156.4 million.
- Across the five-year window, Current Assets retreated 19.48% in 2023 and soared 158.15% in 2024, its largest moves.
- Year by year, Current Assets stood at $99.8 million in 2022, then retreated by 9.93% to $89.9 million in 2023, then surged by 105.9% to $185.1 million in 2024, then jumped by 47.7% to $273.4 million in 2025, then rose by 21.82% to $333.1 million in 2026.
- Per Business Quant, the three latest LQDA Current Assets figures stand at $333.1 million (Q1 2026), $273.4 million (Q4 2025), and $226.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 333.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333.06 Mn |
| Dec 31, 2025 | 273.40 Mn |
| Sep 30, 2025 | 226.72 Mn |
| Jun 30, 2025 | 195.58 Mn |
| Mar 31, 2025 | 177.21 Mn |
| Dec 31, 2024 | 185.11 Mn |
| Sep 30, 2024 | 214.21 Mn |
| Jun 30, 2024 | 147.26 Mn |
| Mar 31, 2024 | 167.94 Mn |
| Dec 31, 2023 | 89.90 Mn |
| Sep 30, 2023 | 82.98 Mn |
| Jun 30, 2023 | 92.89 Mn |
| Mar 31, 2023 | 99.69 Mn |
| Dec 31, 2022 | 99.81 Mn |
| Sep 30, 2022 | 103.06 Mn |
| Jun 30, 2022 | 108.50 Mn |
| Mar 31, 2022 | 61.96 Mn |
| Dec 31, 2021 | 61.28 Mn |
| Sep 30, 2021 | 67.48 Mn |
| Jun 30, 2021 | 71.32 Mn |